Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 3,639.80
-18.80 (-0.51%)
Aug 21, 2026, 3:29 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 454.74 billion as of August 21, 2026. Its market cap has increased by 35.68% in one year.
Market Cap
454.74B
Enterprise Value
450.77B
Revenue
57.76B
Ranking
n/a
PE Ratio
40.08
Stock Price
3,639.80
ChartMarket Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 454.74B, an increase of 80,271.89%. That is a compound annual growth rate of 31.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 454.74B | 31.50% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.10T |
| Mankind Pharma | 988.71B |
| Laurus Labs | 973.53B |
| Aurobindo Pharma | 934.70B |
| Alkem Laboratories | 643.56B |
| Glenmark Pharmaceuticals | 633.96B |
| Ipca Laboratories | 482.98B |
| Gland Pharma | 468.72B |